Dr Marion Sweeney

2018

• Burnett, A. K. et al. 2018. Addition of the mammalian target of rapamycin inhibitor, Everolimus, to consolidation therapy in acute myeloid leukaemia: experience from the UK NCRI AML17 trial. Haematologica 103(10), pp. 1654-1661. (10.3324/haematol.2018.189514)

2014

• Campagna, D. R. et al. 2014. X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations. American Journal of Hematology 89(3), pp. 315-319. (10.1002/ajh.23616)

2011

• Kannengiesser, C. et al. 2011. Missense SLC25A38 variations play an important role in autosomal recessive inherited sideroblastic anemia. Haematologica 96(6), pp. 808-813. (10.3324/haematol.2010.039164)

2007

• Kingston, J., Bowen, D. J., Sweeney, M. C., Lawless, S., Jackson, H. and Worwood, M. 2007. Heteroduplex analysis for the three common HFE variants: methodology, reliablity and analysis of over 5000 requests for testing. Journal of Clinical Pathology 60(11), pp. 1244-1248. (10.1136/jcp.2006.042010)

2005

• Mills, K. I., Gilkes, A. F., Walsh, V., Sweeney, M. and Gale, R. 2005. Rapid and sensitive detection of internal tandem duplication and activating loop mutations of FLT3. British Journal of Haematology 130(2), pp. 203-208. (10.1111/j.1365-2141.2005.05589.x)
• Mills, K. I., Gilkes, A. F., Walsh, V., Sweeney, M., Austin, S. J. and Gale, R. E. 2005. FLT3 gene mutations in AML. British Journal of Haematology 129, pp. 29-29.

2004

• Gilkes, A. F., Walsh, V., Sweeney, M., Austin, S. J., Gale, R. E. and Mills, K. I. 2004. Rapid and quantitative detection of mutations of the FLT3 gene in AML. Blood 104(11), pp. 303A-303A.

2002

• Darley, R. L. et al. 2002. Protein kinase C mediates mutant N-Ras-induced developmental abnormalities in normal human erythroid cells. Blood 100(12), pp. 4185-92. (10.1182/blood-2002-05-1358)

2000

• Mills, K. I. et al. 2000. High FUS/TLS expression in acute myeloid leukaemia samples. British Journal of Haematology 108(2), pp. 316-321. (10.1046/j.1365-2141.2000.01883.x)

1999

• Mills, K. I., Woodgate, L., Gilkes, A. F., Walsh, V., Sweeney, M. C., Brown, G. and Burnett, A. K. 1999. Inhibition of mitochondrial function in HL60 cells is associated with an increased apoptosis and expression of CD14. Biochemical and Biophysical Research Communications 263(2), pp. 294-300. (10.1006/bbrc.1999.1356)
• Woodgate, L. J., Walker, E. J., Gilkes, A. F., Walsh, V., Sweeney, M. C., Mills, K. I. and Burnett, A. 1999. Lovastatin in combination with ATRA may be a potential therapy for leukaemia [Abstract]. British Journal of Haematology 105(Sup.), pp. 74.

1998

• Mills, K. I. et al. 1998. Identification of a retinoic acid responsive aldoketoreductase expressed in HL60 leukaemic cells. FEBS Letters 440(1-2), pp. 158-162. (10.1016/s0014-5793(98)01435-5)